Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2010-06-24
Target enrollment:
Participant gender:
Summary
The study objective is to evaluate the safety and efficacy of patupilone with respect to
early progression and response of patients with non-small cell lung cancer (NSCLC) metastatic
to the brain, who have progressed after chemotherapy, surgery and/or radiation.